CONMED Corporation is a medical technology company that develops, manufactures, and sells surgical devices and equipment for minimally invasive procedures. Operating internationally, the company makes products used by physicians and surgeons in a range of fields, including general surgery, orthopaedics, gynaecology, gastroenterology, and thoracic surgery. Incorporated in 1970, CONMED has its headquarters in Largo, Florida.
With regards to orthopaedic surgery instruments, CONMED offers sports medicine instrumentation, as well as small bone, large bone, and specialty powered surgical instruments. Additionally, the company provides imaging systems for use in minimally invasive surgery procedures. CONMED's general surgery offerings include endo-mechanical instrumentation designed for minimally invasive gastrointestinal and laparoscopic procedures, electrosurgical generators, and a line of cardiac monitoring products.
CONMED stock trades on the NYSE under the ticker CNMD. The company has been listed on the NYSE since 2020, after being transferred from the NASDAQ. Its orthopaedic surgery products are marketed under the CONMED Linvatec, Hall, Shutt, and Concept brands. The company operates multiple manufacturing and design facilities and employs over 3,500 employees across six continents as of November 2021. CONMED's mission is to improve the quality of healthcare through the design and production of innovative, high-quality products.
Learn more about CNMD share price changes by adding it to your eToro virtual portfolio.